COVID | 合法醫療器材資訊網

TheyarebasedonPCR(polymerasechainreaction)technologyorisothermalamplifications,suchasTMA(transcription-mediatedamplification).Themolecular​ ...

Patients inspire and motivate our science. Our ever-growing knowledge of the causes of many chronic, rare and prevalent diseases is driving the development of potential new treatment options derived both from our expertise in human plasma as well as a new class of recombinant antibody drugs and small-molecule candidates. We probe deeply into a range of pathologies – from immunodeficiencies to respiratory disorders to age-related conditions – to create innovative therapeutics that adhere to the highest scientific, ethical and quality standards to help improve people’s lives.